Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis

The Annals of Pharmacotherapy
Kathleen J PincusKristin Watson

Abstract

To review the current literature on the risk of venous thromboembolism (VTE) in patients with chronic liver disease (CLD). Literature was accessed through MEDLINE/PubMed (1996-December 2011) using the search terms liver disease, cirrhosis, venous thromboembolism, deep vein thrombosis, and pulmonary embolism. Relevant observational and population-based studies were included to present background information. Bibliographies of all relevant articles were reviewed for additional citations. Liver disease affects the synthesis of procoagulants and anticoagulants, resulting in hemostatic alterations and abnormal laboratory values. Retrospective studies characterized the VTE incidence to be 0.5-6.3%. Population-based studies reported VTE relative risks of 1.74-2.10 in patients with CLD compared with population controls and VTE odds ratios of 0.9-1.39 for hospitalized patients with CLD compared with controls without liver disease. There is a paucity of data on the use of pharmacologic prophylaxis in patients with CLD. Patients with CLD should be assessed for VTE risk and given VTE prophylaxis when the benefits outweigh the risks. Diagnoses of CLD or elevated international normalized ratio do not confer protection against development of ...Continue Reading

References

Sep 1, 2005·Transfusion·Jodi B SegalUNKNOWN Transfusion Medicine/Hemostasis Clinical Trials Network
Jul 26, 2006·The American Journal of Gastroenterology·Patrick G NorthupCarl L Berg
May 16, 2007·Archives of Internal Medicine·Consuelo HuertaLuis A García Rodríguez
Apr 30, 2008·Digestive Diseases and Sciences·David GulleySuthat Liangpunsakul
May 23, 2008·Cleveland Clinic Journal of Medicine·Amir K JafferAlex C Spyropoulos
Dec 23, 2008·The American Journal of Gastroenterology·Kirstine Kobberøe SøgaardHenrik Toft Sørensen
Jun 9, 2009·Transplantation·Luc MassicotteAndré Roy
Mar 23, 2010·Hepatology International·Cosmas Rinaldi A LesmanaLaurentius A Lesmana
Jun 23, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Harry Wu, Geoffrey C Nguyen
Oct 21, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Lars P BechmannPhilip Hilgard
Nov 26, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Patrick G Northup, Nicolas M Intagliata
Jul 15, 2011·The New England Journal of Medicine·Armando Tripodi, Pier Mannuccio Mannucci
Aug 13, 2011·Thrombosis and Haemostasis·Charles E MahanAlex C Spyropoulos
Nov 2, 2011·Annals of Internal Medicine·Amir QaseemUNKNOWN Clinical Guidelines Committee of the American College of Physicians
Dec 30, 2011·The New England Journal of Medicine·Ajay K KakkarUNKNOWN LIFENOX Investigators

❮ Previous
Next ❯

Citations

Dec 24, 2015·Current Medical Research and Opinion·Timothy H SelfAmanda Howard-Thompson
Oct 9, 2013·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Carmen B SmithJennifer D Twilla
Dec 23, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Dominique-C Valla, Pierre-E Rautou
Jul 3, 2015·Clinical and Translational Gastroenterology·Kirstine Kobberøe SøgaardHenrik Toft Sørensen
Feb 6, 2015·United European Gastroenterology Journal·Markus Peck-RadosavljevicDominique Valla
Mar 14, 2013·The Annals of Pharmacotherapy·Kelly A WalshGeorge A Davis
Aug 28, 2015·The Open Orthopaedics Journal·Francisco Chana-RodríguezJavier Vaquero-Martín
Oct 3, 2015·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Rambaud Jerome, Renolleau Sylvain
Mar 1, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Anuli C AnyanwuDavid J Pinsky
May 3, 2019·Der Anaesthesist·S DehneR von Haken
May 8, 2013·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Charles W MorecroftNeil A Caldwell
Apr 1, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Lisa M Baumann KreuzigerMark T Reding
May 29, 2019·QJM : Monthly Journal of the Association of Physicians·K LapumnuaypolT Chiasakul
Feb 13, 2013·Current Opinion in Critical Care·Eva SchadenKlaus Goerlinger
Feb 11, 2016·The Annals of Pharmacotherapy·Nghi B Ha, Randolph E Regal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine
Carmen B SmithJennifer D Twilla
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Majid Ahmed ShaikhHakim Abro
© 2021 Meta ULC. All rights reserved